Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 7;100(6):292-300.
doi: 10.1212/WNL.0000000000201533. Epub 2022 Nov 22.

Protocol for Deferral of Consent in Acute Stroke Trials

Hannah Faris  1 , Brian Dewar  1 , Mark Fedyk  1 , Dar Dowlatshahi  1 , Bijoy Menon  1 , Richard H Swartz  1 , Michael D Hill  1 , Michel Shamy  2
Affiliations

Protocol for Deferral of Consent in Acute Stroke Trials

Hannah Faris et al. Neurology. .

Abstract

The challenges of conducting hyperacute stroke research and obtaining informed consent have been increasingly recognized within the stroke research community in recent years. Deferral of consent, in which a patient is enrolled in a trial and then provides consent at some point thereafter, is increasingly used to enroll patients into hyperacute stroke trials in Canada and Europe, although it is not permitted in the United States. Deferral of consent offers several potential advantages-quicker door-to-randomization, increased enrolment, decreased selection bias-but these must be balanced against the risk of enrolling patients against their wishes. We seek to minimize the attendant risks of deferral of consent by offering practical guidance regarding how to conduct acute stroke trials using deferral of consent. Building on existing guidelines and recent experiences with deferral of consent in acute stroke trials, we have developed a protocol for the use of deferral of consent that aims to maximize patient involvement while minimizing ethical and scientific risks.

PubMed Disclaimer

Comment in

References

    1. Kompanje EJO, van Dijck JTJM, Chalos V, et al. . Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke. Lancet Neurol. 2020;19(12):1033-1042. doi: 10.1016/s1474-4422(20)30276-3. - DOI - PubMed
    1. Tu JV, Willison DJ, Silver FL, et al. . Impracticability of informed consent in the registry of the Canadian stroke network. N Engl J Med. 2004;350(14):1414-1421. doi: 10.1056/nejmsa031697. - DOI - PubMed
    1. Bateman BT, Meyers PM, Schumacher HC, Mangla S, Pile-Spellman J. Conducting stroke research with an exception from the requirement for informed consent. Stroke. 2003;34(5):1317-1323. doi: 10.1161/01.str.0000065230.00053.b4. - DOI - PubMed
    1. Sajobi T, Singh N, Almekhlafi MA, et al. . Alteplase compared to tenecteplase in patients with acute ischemic stroke (AcT) trial: protocol for a pragmatic registry linked randomized clinical trial. Stroke: Vasc Interv Neurol. 2022:e12329. doi: 10.1161/svin.121.000447. - DOI
    1. Menon BK, Buck BH, Singh N, et al. , AcT Trial Investigators. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. - DOI - PubMed